ESCMID eLibrary

Search results
Icon explanation
Icon explanation
close








Found 7 results
-
P1536
Potentiation of cefepime by the boronate VNRX-5133 versus Gram-negative bacteria with known beta-lactamases
23 April 2018
Session: VNRX- 5133 plus cefepime: in vitro and in vivo data
-
P1033
Nacubactam (RG6080) alone and in combination against metallo-beta-lactamase (MBL)-producing Enterobacteriaceae
22 April 2018
Session: Carbapenem plus carbapenemase inhibitor combinations: in vitro and in vivo data
-
EP0399
Activity of novel pyrrolocytosine protein synthesis inhibitors against multi-resistant Gram-negative bacteria, including carbapenemase producers and those with MCR-1
23 April 2017
Session: New antibiotics - new approaches
-
P1265
WCK 4282 (high-dose cefepime-tazobactam) against multi-resistant Gram-negative bacteria
11 April 2016
Session: Cefepime-tazobactam
-
S061
Con
25 April 2015
Session: Can PK/PD provide all the answers for breakpoints & antibiotic dosing? Pro-Con Debate
-
S004
Which role and indications for new beta-lactams and beta-lactamase inhibitor-combinations?
25 April 2015
Session: New antibacterial drugs
-
P1447
Activity of BAL30072, alone and combined with beta-lactamase inhibitors or meropenem, against carbapenem-resistant Enterobacteriaceae
01 April 2012
Session: New antimicrobial agents against old and new protein targets
Search narrowed by
-
Topics
-
Type of material
-
Time period